The candidate must have an MS in Statistics or a related field, practical understanding of statistical modelling, strong performance in academics or industry, ability to work effectively in a team, good time management and prioritization skills, passion for statistics, open mindset to evolving methodologies, proactive and self-motivated approach, strong communication and influencing skills, and an MS/MSc degree in Statistics/Biostatistics or a related discipline with graduation by August 2024 and fluency in English.

The candidate will provide statistical input to clinical studies, influence development plans and strategies, build relationships, implement novel methodologies, and support drug development in all stages.

Research & Development

United Kingdom

London

A competitive base salary

An annual bonus based on company performance

Access to healthcare and wellbeing programmes, pension plan membership, savings programmes, time off and childcare support

Employee recognition programmes that reward exceptional achievements

Large

GSK, or GlaxoSmithKline, is a company that operates in the pharmaceutical and healthcare industry. They are involved in researching, developing, manufacturing, and selling a wide range of prescription medicines, vaccines, and consumer healthcare products. GSK's ultimate aim is to improve the quality of human life by providing innovative and effective healthcare solutions to people worldwide. Their commitment lies in focusing on scientific excellence, developing cutting-edge medicines and vaccines, and addressing global health challenges to help people live longer, healthier lives.

Science & Healthcare

<ul><li>Join our team of industry-leading experts in data analysis and methodologic research in embedding quantitative decision-making in order to take smart risks and improve the probability of study and program success. Our end-to-end project support model ensures that our statisticians collaborate across the entire range of drug development, from early clinical development, to registration and marketed product support.&nbsp;</li><li>If you’re a graduate with the talent and ambition to lead others, we’ll help you develop the skills to be one of our Future Leaders. Over two years, our Future Leaders Programme will challenge and support you to grow professionally and personally. You will have hands-on experiences and mentoring to allow you to explore these areas of applied statistics, biostatistics &amp; machine learning and inform future career decisions. Throughout the programme, you’ll work closely with multidisciplinary colleagues and stakeholders to progress the portfolio to get ahead of disease together.</li></ul>The Statistics FLP within Biostatistics provides three rotations across the following areas:<ul><li>Oncology Statistics&nbsp;has a commitment to the discovery and development of new oncology therapies with the life-changing potential of helping patients with cancer, supporting Disease Area Strategy, Medical Market Access and our clinical development programs in four key areas of cancer research:&nbsp;Immuno-Oncology, Oncology Cell &amp; Gene Therapy, Synthetic Lethality and Cancer Epigenetics.&nbsp;</li><li>Development Statistics&nbsp;is proud to support drug development efforts in Immunology, Hepatology and Gastro-intestinal, Respiratory, Speciality (which ranges from neurological conditions such as Parkinson’s and Alzheimer’s to heart disease and bacterial infections), HIV, Global Health (which covers infectious diseases like malaria and TB that impact the developing world) and - most recently - in the fight to treat the COVID-19 pandemic.</li><li>Early Development Statistics&nbsp;have the exciting opportunity of supporting all therapeutic areas; providing statistical and strategic insight into the design and implementation of end to end clinical development strategies, from selection of promising candidates through to later phase drug development. The team strive to use novel clinical trial designs and innovative methodologies, including Bayesian techniques, to quantify risk and enable smart decision making</li><li>Vaccines Statisticians&nbsp;are at the forefront of transformations in the vaccines industry to combat the spread of infectious diseases and treat chronic conditions to the benefit of millions of people worldwide.&nbsp;Supporting all phases of vaccines development, Vaccines Statistics is a highly effective and influential strategic partner consisting of five groups:&nbsp;Clinical Assay Statistics,&nbsp;Early and Exploratory Clinical Statistics, and three&nbsp;Clinical and Epidemiological Statistics groups&nbsp;aligned to the Global Vaccines Research and development Centres.</li><li>CMC Statistics&nbsp;(Chemistry, Manufacturing, and Controls) group serves as in-house statistical consulting for pharmaceutical R&amp;D, providing statistical guidance for early-stage manufacturing and production. CMC statisticians work with scientists to design and analyze experiments in the early stages where compound and analytical method/development are being refined. This may include activities such as sample size calculations, design of experiments, equivalence testing, intermediate precision, specification setting, and stability.</li><li>Translational Statistics&nbsp;(Tstat) is a functional line within Biostatistics providing quantitative support to translational medicine practice. Tstat is accountable for all statistical elements of the translational strategy from laboratory to clinic; integrating relevant sources of data into quantitative models that predict potential outcomes in humans, ensuring clear and defensible decision making rules for progression, and communication of the biomarker strategy at governance boards. In addition, Tstat also provides analytical support to precision medicine strategy, that is finding biomarkers, which help identifying patient subpopulations that can get the most benefit from the treatments.</li></ul>

Join our team of industry-leading experts in data analysis and methodologic research in embedding quantitative decision-making in order to take smart risks and improve the probability of study and program success. Our end-to-end project support model ensures that our statisticians collaborate across the entire range of drug development, from early clinical development, to registration and marketed product support. If you’re a graduate with the talent and ambition to lead others, we’ll help you develop the skills to be one of our Future Leaders. Over two years, our Future Leaders Programme will challenge and support you to grow professionally and personally. You will have hands-on experiences and mentoring to allow you to explore these areas of applied statistics, biostatistics & machine learning and inform future career decisions. Throughout the programme, you’ll work closely with multidisciplinary colleagues and stakeholders to progress the portfolio to get ahead of disease together.The Statistics FLP within Biostatistics provides three rotations across the following areas:Oncology Statistics has a commitment to the discovery and development of new oncology therapies with the life-changing potential of helping patients with cancer, supporting Disease Area Strategy, Medical Market Access and our clinical development programs in four key areas of cancer research: Immuno-Oncology, Oncology Cell & Gene Therapy, Synthetic Lethality and Cancer Epigenetics. Development Statistics is proud to support drug development efforts in Immunology, Hepatology and Gastro-intestinal, Respiratory, Speciality (which ranges from neurological conditions such as Parkinson’s and Alzheimer’s to heart disease and bacterial infections), HIV, Global Health (which covers infectious diseases like malaria and TB that impact the developing world) and - most recently - in the fight to treat the COVID-19 pandemic.Early Development Statistics have the exciting opportunity of supporting all therapeutic areas; providing statistical and strategic insight into the design and implementation of end to end clinical development strategies, from selection of promising candidates through to later phase drug development. The team strive to use novel clinical trial designs and innovative methodologies, including Bayesian techniques, to quantify risk and enable smart decision makingVaccines Statisticians are at the forefront of transformations in the vaccines industry to combat the spread of infectious diseases and treat chronic conditions to the benefit of millions of people worldwide. Supporting all phases of vaccines development, Vaccines Statistics is a highly effective and influential strategic partner consisting of five groups: Clinical Assay Statistics, Early and Exploratory Clinical Statistics, and three Clinical and Epidemiological Statistics groups aligned to the Global Vaccines Research and development Centres.CMC Statistics (Chemistry, Manufacturing, and Controls) group serves as in-house statistical consulting for pharmaceutical R&D, providing statistical guidance for early-stage manufacturing and production. CMC statisticians work with scientists to design and analyze experiments in the early stages where compound and analytical method/development are being refined. This may include activities such as sample size calculations, design of experiments, equivalence testing, intermediate precision, specification setting, and stability.Translational Statistics (Tstat) is a functional line within Biostatistics providing quantitative support to translational medicine practice. Tstat is accountable for all statistical elements of the translational strategy from laboratory to clinic; integrating relevant sources of data into quantitative models that predict potential outcomes in humans, ensuring clear and defensible decision making rules for progression, and communication of the biomarker strategy at governance boards. In addition, Tstat also provides analytical support to precision medicine strategy, that is finding biomarkers, which help identifying patient subpopulations that can get the most benefit from the treatments.

R&D Statistics (Biostatistics) Future Leaders Programme - UK, 2024

Requirements

Responsibilities

GSK

Mission & Purpose

Benefits

A competitive base salary

An annual bonus based on company performance

Access to healthcare and wellbeing programmes, pension plan membership, savings programmes, time off and childcare support

Employee recognition programmes that reward exceptional achievements